FR2883886B1 - Methode d'obtention de variants solubles ou mieux exprimes d'une proteine d'interet - Google Patents

Methode d'obtention de variants solubles ou mieux exprimes d'une proteine d'interet

Info

Publication number
FR2883886B1
FR2883886B1 FR0503366A FR0503366A FR2883886B1 FR 2883886 B1 FR2883886 B1 FR 2883886B1 FR 0503366 A FR0503366 A FR 0503366A FR 0503366 A FR0503366 A FR 0503366A FR 2883886 B1 FR2883886 B1 FR 2883886B1
Authority
FR
France
Prior art keywords
interest
protein
better express
obtaining soluble
express variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0503366A
Other languages
English (en)
Other versions
FR2883886A1 (fr
Inventor
Marc Delcourt
Laurent Ducher
Stephane Blesa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomethodes SA
Original Assignee
Biomethodes SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomethodes SA filed Critical Biomethodes SA
Priority to FR0503366A priority Critical patent/FR2883886B1/fr
Priority to PCT/FR2006/000257 priority patent/WO2006106193A1/fr
Publication of FR2883886A1 publication Critical patent/FR2883886A1/fr
Application granted granted Critical
Publication of FR2883886B1 publication Critical patent/FR2883886B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR0503366A 2005-04-05 2005-04-05 Methode d'obtention de variants solubles ou mieux exprimes d'une proteine d'interet Expired - Fee Related FR2883886B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0503366A FR2883886B1 (fr) 2005-04-05 2005-04-05 Methode d'obtention de variants solubles ou mieux exprimes d'une proteine d'interet
PCT/FR2006/000257 WO2006106193A1 (fr) 2005-04-05 2006-02-03 Methode d'obtention de variants solubles ou mieux exprimes d'une proteine d'interet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0503366A FR2883886B1 (fr) 2005-04-05 2005-04-05 Methode d'obtention de variants solubles ou mieux exprimes d'une proteine d'interet

Publications (2)

Publication Number Publication Date
FR2883886A1 FR2883886A1 (fr) 2006-10-06
FR2883886B1 true FR2883886B1 (fr) 2010-12-03

Family

ID=35414535

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0503366A Expired - Fee Related FR2883886B1 (fr) 2005-04-05 2005-04-05 Methode d'obtention de variants solubles ou mieux exprimes d'une proteine d'interet

Country Status (2)

Country Link
FR (1) FR2883886B1 (fr)
WO (1) WO2006106193A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448087B1 (en) * 1997-12-12 2002-09-10 The Regents Of The University Of California Method for determining and modifying protein/peptide solubility
DK1242457T3 (da) * 1999-12-28 2004-12-20 Esbatech Ag Intracellulære antistoffer [intracellulære antistoffer] med defineret struktur, der er stabil i et reducerende miljö, og anvendelse deraf
WO2001060840A2 (fr) * 2000-02-14 2001-08-23 Board Of Regents, The University Of Texas System Estimation des proteines/de la solubilite et du repliage par complementation structurelle
US20030119094A1 (en) * 2001-09-24 2003-06-26 Irm Llc Solubility reporter gene constructs
GB2400102A (en) * 2003-03-31 2004-10-06 Sense Proteomic Ltd Uses of Ble proteins and bleomycin

Also Published As

Publication number Publication date
WO2006106193A1 (fr) 2006-10-12
FR2883886A1 (fr) 2006-10-06

Similar Documents

Publication Publication Date Title
FR13C0015I2 (fr) Composes d'aminoheteroaryle enantiomeriquement purs utilises comme inhibiteurs de proteine kinase
MA28370A1 (fr) Derives de alkylpiperazine-et alkylhomopiperazine-carboxylates, leur preparation et leur application en tant qu'inhibiteurs de l'enzyme faah
FR2918179B1 (fr) Methode pour estimer la permeabilite d'un reseau de fractures a partir d'une analyse de connectivite
CL2008000069A1 (es) Metodo de preparacion de compuestos derivados de 3,4-dihidroquinolina.
DE60301868D1 (de) Blutzuckerspiegelmessgerät
MA28922B1 (fr) Nouveaux derives de phenylaminopyrimidine en tant qu'inhibiteurs de bcr-abl kinase
DE602005025450D1 (de) Homokinetisches gelenk
SI1876236T1 (sl) Protitelo, ki funkcionalno nadomesti faktor viii za koagulacijo krvi
FR2904315B1 (fr) Composes pyridaziniques et pyrroliques, procedes d'obtention et applications
EP1820988A4 (fr) Joint à vitesse constante
SI1833995T1 (sl) Identifikacija tarč RNA z uporabo helikaz
DE602004021323D1 (de) Gleichlauffestgelenk
DE602005026025D1 (de) Kardangelenk
DE602004009249D1 (de) Gleichlaufgelenk
DE602004023173D1 (de) Tripode-Gleichlaufgelenk.
FR2875398B1 (fr) Implant articulaire d'interposition
EP1845274A4 (fr) Joint universel à vitesse constante de glissement
WO2005094898A3 (fr) Compositions de protéines chimiquement modifiées et procédés
DE602004004206D1 (de) Gleichlaufgelenk
MA28367A1 (fr) Derives d'heteroaryl-alkylcarbamates, leur preparation et leur application comme inhibiteurs de l'enzyme faah
FR2878850B1 (fr) Derives de l'inositol-1-phosphate
FR2883886B1 (fr) Methode d'obtention de variants solubles ou mieux exprimes d'une proteine d'interet
FR2887462B1 (fr) Appareil de gymnastique de type "step" basculant ou "marche basculante"
DE602004013222D1 (de) Gleichlauf-Universalgelenk
FR2879635B1 (fr) Connecteur d'ossature

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 11

ST Notification of lapse

Effective date: 20161230